Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04
Schumacher, K.
Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft . 176(5): 239-240
2000
ISSN/ISBN: 0179-7158 PMID: 10847122 Document Number: 523426
Document emailed within 1 workday
Related Documents
Lu, J.-w.; Zhou, Z.-f.; Yin, B.-j.; Liu, D.-l.; Feng, J.-f.; Zhu, L.-j.; Pan, L.-x. 2005: Chronomodulated chemotherapy of oxaliplatin, 5-fluorouracil and folinic acid for advanced gastric cancer Zhonghua Zhong Liu Za Zhi 27(11): 695-697Chauffert, B.; Bonnotte, B.; Chvetzoff, G.; Flesch, M. 1998: The major response of metastatic kidney cancer to the combination of oxaliplatin, 5-fluorouracil and folinic acid (FOX-FOL) Presse Medicale 27(18): 859
Natoli, C.; Scognamiglio, M.T.; Martino, M.T.; Irtelli, L.; De Tursi, M.; Cianchetti, E.; Mascitelli, E.; Tinari, N.; Iacobelli, S. 2000: Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer Anticancer Research 20(2b): 1253-1256
Hiddemann, W.; Ruelfs, C.; Ottensmeier, C.; Rückle, H.; Musch, E.; Koch, O.; van de Loo, J. 1992: Interleukin-2 followed by fluorouracil and folinic acid in refractory colorectal cancer--results of a clinical phase Ii study Seminars in Oncology 19(2 Suppl 3: 225-227
Neyns, B.; Van Nieuwenhove, Y.; Aerts, M.; Fontaine, C.; Vermeij, J.; Schallier, D.; Decoster, L.; De Mey, J.; Vandenbroucke, F.; Hoorens, A.; Delvaux, G.; De Gréve, J. 2006: Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases Anticancer Research 26(1b): 611-619
Tsavaris, N.; Zinelis, A.; Karvounis, N.; Beldecos, D.; Mylonacis, N.; Zamanis, N.; Bacoyannis, C.; Valilis, P.; Antonopoulos, A.; Kosmidis, P. 1990: Multimodal biochemical modulation of 5-fluorouracil activity in advanced colorectal cancer with allopurinol, folinic acid and dipyridamol Journal of Chemotherapy 2(2): 123-126
Klaassen, U.; Harstrick, A.; Wilke, H.; Seeber, S. 1996: Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer Seminars in Oncology 23(1 Suppl 1: 44-47
Khayat, D.; Gil-Delgado, M.; Antoine, E.C.; Coeffic, D.; Benhammouda, A.; Grapin, J.P.; Bastian, G. 1998: European experience with irinotecan plus fluorouracil/folinic acid or mitomycin Oncology 12(8 Suppl. 6): 64-67
Slee, P.H.T.J.; Rodenburg, C.J.; Nortier, J.W.R.; van Bochove, A. 2004: A phase i dose-escalating study of docetaxel plus folinic acid and 5-fluorouracil in anthracycline-pretreated patients with metastatic breast cancer Netherlands Journal of Medicine 62(9): 314-319
Bernhard, H.; Klein, O.; Meyer zum Büschenfelde, K.H.; Knuth, A. 1992: Treatment of refractory colorectal carcinomas with fluorouracil, folinic acid, and interferon alfa-2a Seminars in Oncology 19(2 Suppl 3: 204-207
Grem, J.L.; Hoth, D.F.; Hamilton, J.M.; King, S.A.; Leyland-Jones, B. 1987: Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid Cancer Treatment Reports 71(12): 1249-1264
Colucci, G.; Maiello, E.; Leo, S.; Giuliani, F.; Pedicini, A.; Pezzella, G.; Valori, V.; Galetta, D.; Contillo, A.; Prete, F. 1994: Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM) Anticancer Research 14(5b): 2157-2162
de Souza, P. 1993: A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma Medical Journal of Australia 158(12): 866
Breul, J.; Tief, G.; Hartung, R. 1996: Enhancement of 5-fluorouracil cytotoxicity by folinic acid in different cell-lines of human renal cell carcinoma European Journal of Medical Research 1(7): 339-342
Grem, J.L. 1991: Adjuvant treatment of node-positive colon carcinoma with levamisole and 5-fluorouracil Oncology 5(3): 63-70; 73; Discussion: 73-74
Shaib, W.; Lee, V.; Saif, M.W. 2009: Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity In Vivo 23(5): 821-826
Van Cutsem, E.; Blijham, G.H. 1999: Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group Seminars in Oncology 26(1 Suppl. 5): 13-20
Failli, A.; Legitimo, A.; Orsini, G.; Castagna, M.; Spisni, R.; Miccoli, P.; Consolini, R. 2013: Antiproliferative effects of 5-fluorouracil and oxaliplatin in colon cancer cell lines: comparison of three different cytotoxicity assays Journal of Biological Regulators and Homeostatic Agents 27(1): 275-284
Iigo, M.; Glazer, R.I. 1985: Antagonistic effect of polyinosinic-polycytidylic acid on the cell lethality produced by 5-fluorouracil in human colon carcinoma cells in vitro Cancer Research 45(5): 1953-1957
Kalofonos, H.P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K.N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G. 2010: Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer Anticancer Research 30(10): 4325-4333